I know the question about whether COVID-19 could also cause some patients to come down with ME/CFS has been discussed on the Forum, but I could not locate those threads or posts when I went searching for them. So, I am making a new thread for a link to an article by Cort Johnson (published today on the Simmaron Research website) to add to the discussion because I think it provides some additional information/thoughts on this topic.
@CortWill COVID-19 Leave An Explosion of ME/CFS Cases in its Wake?
April 2, 2020
. . .
It’s possible that post-SARS illness cohort will be so large, affect so many younger people, and cause such losses in economic productivity that the NIH and other research institutions will, this time, focus considerable resources on the post-infectious consequences of having a severe infection.
The Dubbo studies and others have invariably found that the type of infection (bacterial or viral), the type of tissue it primarily infects (respiratory system, gut, brain) doesn’t matter. For the most part, after a period of time, the post-infectious illness patients look like each other: they look like ME/CFS/FM patients.
Using post-infectious ME/CFS patients to help understand what post-SARS patients will be going through seems to make perfect sense as well. Avindra Nath’s small, but comprehensively studied, ME/CFS group in the NIH’s intramural study, could provide clues for post-SARS studies. Expanding Nath’s ME/CFS cohort and using the study to help understand the massive hit SARS-CoV-2 is likely to produce, not today, not tomorrow, not in three months, but in the years to follow would make perfect sense.
Even more impactful would be rigorously following and studying the mass post-COVID-19 cohort that will emerge in order to understand how post-infectious diseases emerge and how to treat them. . . .